WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Storms damage homes in Oklahoma and Kansas. But in Houston, most power is restored
Boao Forum for Asia Focuses on Green Recovery, Sustainable Development
China to Offer 1 Mln Internship Posts for Job Seekers
Farmers Work in Sugar Cane Fields in Dahua Township, Guangxi
With Djokovic awaiting the winner, Murray trails Hanfmann at rain
ICH Drives Rural Revitalization in Guizhou
Across China: Gen Z Injects New Life into Traditional Tibetan Costumes
Travis Kelce downs whiskey shot on slice of bread at Kelce Jam without Taylor Swift
World Book Day Marked Across China
Nadal returns to Roland Garros to practice amid doubts over fitness and form
Across China: Gen Z Injects New Life into Traditional Tibetan Costumes